Skip to Main Content
Qurgen Qurgen
Menu Button

2026

Brand Icon
  • Prof Wang was invited to attend Tigermed’s ASCO Pre-Event Webinar as a Speaker to introduce Qurgen’s breakthrough cell converting cancer therapy and recent progress in its Phase I clinical trial.

Recent news & press

Apr. 2026
no infusion related reaction (IRR) has occurred during the 48-hour continuous infusion by pump, this...
Learn More
Mar. 2026
Qurgen has completed SON-DP treatment for multiple late-stage solid tumor patients for over 18-months at low dose levels...
Learn More